Quince Therapeutics, Inc. (QNCX)
0.1023
-0.01
(-6.49%)
USD |
NASDAQ |
Mar 06, 16:00
0.1025
0.00 (0.00%)
After-Hours: 20:00
Quince Therapeutics Cash from Investing (TTM) : 26.02M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -16.87M |
| Ocular Therapeutix, Inc. | -11.88M |
| BioXcel Therapeutics, Inc. | 0.00 |
| Gossamer Bio, Inc. | 136.42M |
| Ernexa Therapeutics, Inc. | -0.022M |